World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
15957
World Ranking
2245
National Ranking
88

Kelli P. A. MacDonald publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kelli P. A. MacDonald sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 224 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kelli P. A. MacDonald D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kelli P. A. MacDonald sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kelli P. A. MacDonald is affiliated with the QIMR Berghofer Medical Research Institute in Australia. Their research spans across multiple disciplines including medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Within these broad areas, their work focuses on several subfields such as immunology, molecular biology, hematology, neurology, and hepatology.

The scientist's studies address a range of topics, including:

  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Immune cells in cancer
  • Protein Degradation and Inhibitors
  • Liver physiology and pathology

MacDonald has contributed to multiple recent publications that highlight the diversity of their research interests. Some of these papers include:

  • "Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner," 2020, published in Cell
  • "BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection," 2021, published in Cell
  • "ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis," 2021, published in JHEP Reports
  • "Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force," 2022, published in Transplantation and Cellular Therapy
  • "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report," 2021, published in Transplantation and Cellular Therapy

Frequent collaboration has been established with several co-authors, including:

  • Bruce R. Blazar
  • Geoffrey R. Hill
  • Jana Vukovic
  • Christian Engwerda
  • Robert Zeiser

The scientist's work is commonly published in prominent venues such as Blood, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, Cell, and Transplantation and Cellular Therapy.

Best Publications

  • Characterization of human blood dendritic cell subsets.

    Kelli P A MacDonald;David J Munster;Georgina J Clark;Andrzej Dzionek

  • Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling

    David A Hume;Kelli P A MacDonald

  • An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

    Kelli P. A. MacDonald;James S. Palmer;Stephen Cronau;Elke Jane Seppanen

  • Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner

    Emily F. Willis;Kelli P.A. MacDonald;Quan H. Nguyen;Adahir Labrador Garrido

  • Chronic graft-versus-host disease: biological insights from preclinical and clinical studies

    Kelli P. A. MacDonald;Geoffrey R. Hill;Geoffrey R. Hill;Bruce R. Blazar

  • Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease

    Motoko Koyama;Rachel D Kuns;Stuart D Olver;Neil C Raffelt

  • Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions

    Lynette Beattie;Lynette Beattie;Amy Sawtell;Jason L. Mann;Teija C.M. Frame

  • CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease

    Kylie A. Alexander;Ryan Flynn;Katie E. Lineburg;Rachel D. Kuns

  • Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

    Ryan P Flynn;Jing Du;Rachelle G. Veenstra;Dawn K Reichenbach

  • A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment

    Frederic Sierro;Maximilien Evrard;Simone Rizzetto;Michelle Melino

  • The Colony-Stimulating Factor 1 Receptor Is Expressed on Dendritic Cells during Differentiation and Regulates Their Expansion

    Kelli P A MacDonald;Vanessa Rowe;Helen M Bofinger;Ranjeny Thomas

  • Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

    Glen A. Kennedy;Glen A. Kennedy;Antiopi Varelias;Slavica Vuckovic;Laetitia Le Texier

  • Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

    Jason A. Dubovsky;Ryan P Flynn;Jing Du;Bonnie K. Harrington

  • Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.

    Masato Kato;Kylie J. McDonald;Seema Khan;Ian L. Ross

  • Functional CD40 ligand is expressed by T cells in rheumatoid arthritis.

    K. P. A. MacDonald;Y. Nishioka;P. E. Lipsky;R. Thomas

  • Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.

    Ryan Flynn;Katelyn Paz;Jing Du;Dawn K. Reichenbach

  • BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.

    Richard J. Mills;Sean J. Humphrey;Patrick R.J. Fortuna;Mary Lor

  • The biology of graft-versus-host disease: experimental systems instructing clinical practice

    Kate A. Markey;Kate A. Markey;Kelli P. A. MacDonald;Geoffrey R. Hill;Geoffrey R. Hill

  • Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma

    Geoffrey R. Hill;Stuart D. Olver;Rachel D. Kuns;Antiopi Varelias

  • NKT cell–dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs

    Edward S. Morris;Edward S. Morris;Kelli P.A. MacDonald;Vanessa Rowe;Tatjana Banovic

  • Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation.

    Vanessa Rowe;Tatjana Banovic;Tatjana Banovic;Kelli P. MacDonald;Kelli P. MacDonald;Rachel Kuns;Rachel Kuns

Frequent Co-Authors

Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Andrew D. Clouston
Andrew D. Clouston University of Queensland
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Christian R. Engwerda
Christian R. Engwerda QIMR Berghofer Medical Research Institute
Ranjeny Thomas
Ranjeny Thomas University of Queensland
Jonathan S. Serody
Jonathan S. Serody University of North Carolina at Chapel Hill
Ivan Maillard
Ivan Maillard University of Pennsylvania
Angela Panoskaltsis-Mortari
Angela Panoskaltsis-Mortari University of Minnesota
Leo Luznik
Leo Luznik Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare roles, many of which can be advanced through specialized online programs. For those interested in combining immunology knowledge with mental health, exploring affordable pmhnp programs can be an excellent pathway to become a Psychiatric Mental Health Nurse Practitioner.

For nursing professionals aiming to enhance their credentials, understanding how much do dnps make provides valuable insight into salary expectations across states after earning a Doctor of Nursing Practice degree. This can guide financial planning and career decisions.

Nurses looking to specialize further may consider transitioning through a bridge program. The fnp to acute care np bridge program offers a streamlined path to move from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions, expanding clinical expertise and job opportunities.

For those seeking an accelerated pathway into advanced practice, nurse practitioner accelerated program options provide fast-track education to become a Nurse Practitioner. These programs balance rigorous curriculum with flexible online delivery, ideal for busy professionals.

Best Scientists Citing Kelli P. A. MacDonald

Trending Scientists

Recently Published Articles